Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management reveal that customers have made binding, at-risk commitments to a product, service, or platform that is NOT yet generally available or generating meaningful revenue — for example: signed purchase orders, prepaid orders, non-refundable deposits, minimum-purchase or take-or-pay contracts, funded development agreements, or customers contractually locked in or co-funding a launch — for something management itself describes as still in development, in pilot/beta, awaiting certification/approval, or otherwise not yet shipping at scale?
Answer YES only if BOTH of the following are clearly present in management's own words (including management's direct answers to analysts):
(1) The customer commitment is real and costly to the customer — money has been paid, a contract has been signed, or the customer would face a genuine penalty, forfeited deposit, or wasted co-investment by walking away. Casual expressions of interest, pipeline, LOIs, MOUs, pilot participation without payment, "strong inbound interest," or awards with no committed spend do NOT count.
AND
(2) The thing being committed to is NOT yet a normal, generally available, revenue-generating offering — management itself frames it as upcoming, pre-launch, in qualification, in pilot, pending approval, or ramping toward first shipments.
Answer NO if: the commitments are for an existing, already-shipping product (ordinary backlog or routine orders); the evidence is only vague demand language ("customers can't wait," "huge interest") with no signed or paid commitment; the only mention comes from an analyst's question that management does not itself confirm; or the arrangement is a standard channel/inventory stocking program with no end-customer commitment.
Use only the supplied transcript. Answer only YES or NO.
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our
methodology.